Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam 1105 AZ, The Netherlands.
Scientific Research Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
Trans R Soc Trop Med Hyg. 2023 Mar 1;117(3):197-204. doi: 10.1093/trstmh/trac101.
Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce.
Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression.
Anti-HAV prevalence was 58.3% (95% CI 55.4 to 61.4%) and higher prevalence was independently associated with belonging to the Tribal or Indigenous population and older age. Anti-HEV prevalence was 3.7% (95% CI 2.6 to 5.0%) and higher prevalence was associated with Tribal and Creole ethnicity and older age.
In Suriname, exposure to HAV is consistent with a very low endemic country and exposure to HEV was rare. Both viruses were more prevalent in specific ethnic groups. As anti-HAVantibodies were less frequently found in younger individuals, they could be susceptible to potential HAV outbreaks and might require HAV vaccination.
甲型肝炎病毒(HAV)和戊型肝炎病毒(HEV)通过肠道传播,是中低收入国家急性肝炎的常见病因。HEV 也具有动物源性感染的特征,在高收入国家普遍存在。南美洲中收入国家苏里南的 HAV 和 HEV 流行情况数据稀缺。
分别对 944 名和 949 名随机选择的在苏里南首都帕拉马里博学术医院急诊科就诊的患者的血清样本进行了甲型肝炎病毒抗体(抗-HAV)和戊型肝炎病毒抗体(抗-HEV)分析。使用多变量逻辑回归评估了抗-HAV 和抗-HEV 阳性血清学的决定因素。
抗-HAV 流行率为 58.3%(95%CI 55.4%至 61.4%),较高的流行率与属于部落或土著人口以及年龄较大独立相关。抗-HEV 流行率为 3.7%(95%CI 2.6%至 5.0%),较高的流行率与部落和克里奥尔种族以及年龄较大有关。
在苏里南,HAV 的暴露情况与极低的地方性国家一致,而 HEV 的暴露情况则很少见。这两种病毒在特定族群中更为普遍。由于年轻个体中较少发现抗-HAV 抗体,他们可能容易受到潜在的 HAV 爆发的影响,可能需要接种 HAV 疫苗。